drugset / Trial / NCT07651917
Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders
Phase 4
Not yet recruiting
50 enrolled
University of Zurich
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov · collab
RandomizedCrossoverSingle-blindTreatment
Summary
Exposure to high altitudes, defined as locations above 2500 m, has been shown to cause cognitive alternations due to reduced blood oxygenation (SpO2). However, it remains to be determined whether cognitive changes are present in highlanders living at moderate altitudes (2500 m) and whether cognitive alterations are reversible with supplemental oxygen therapy (SOT).
Timeline
- Start
- 2026-06-18
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | supplemental oxygen therapy | Unknown | 5 unknown | Intranasal |